Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus

Cancer Research
Nicola J CampAngela Cox

Abstract

The findings from genome-wide association studies hold enormous potential for novel insight into disease mechanisms. A major challenge in the field is to map these low-risk association signals to their underlying functional sequence variants (FSV). Simple sequence study designs are insufficient, as the vast numbers of statistically comparable variants and a limited knowledge of noncoding regulatory elements complicate prioritization. Furthermore, large sample sizes are typically required for adequate power to identify the initial association signals. One important question is whether similar sample sizes need to be sequenced to identify the FSVs. Here, we present a proof-of-principle example of an extreme discordant design to map FSVs within the 2q33 low-risk breast cancer locus. Our approach employed DNA sequencing of a small number of discordant haplotypes to efficiently identify candidate FSVs. Our results were consistent with those from a 2,000-fold larger, traditional imputation-based fine-mapping study. To prioritize further, we used expression-quantitative trait locus analysis of RNA sequencing from breast tissues, gene regulation annotations from the ENCODE consortium, and functional assays for differential enhancer act...Continue Reading

References

Nov 1, 1973·Journal of the National Cancer Institute·H D SouleM Brennan
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Feb 13, 2007·Nature Genetics·Angela CoxUNKNOWN Breast Cancer Association Consortium
May 11, 2010·Nature Genetics·Clare TurnbullDouglas F Easton
Oct 15, 2010·Nature Biotechnology·Bradley E BernsteinJames A Thomson
Nov 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nicola J CampAngela Cox
Jun 23, 2012·Nature·Philip J StephensMichael R Stratton
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Nov 30, 2012·Nucleic Acids Research·Kate R RosenbloomW James Kent
Aug 22, 2013·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Steven N HartJean-Pierre Kocher
Aug 1, 2014·International Journal of Cancer. Journal International Du Cancer·Jennifer H BarrettUNKNOWN GenoMEL Consortium
Sep 15, 2014·Nature Genetics·Ali Amin Al OlamaChristopher A Haiman
Nov 5, 2014·Nature·Kyle Kai-How FarhBradley E Bernstein
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Nicola J CampAngela Cox
© 2022 Meta ULC. All rights reserved